Algert Global LLC Artivion, Inc. Transaction History

Algert Global LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$16.7 - $21.63 $290,246 - $375,929	-17,380 Reduced 64.2%	9,690 $205,000
Q4 2023 Feb 14, 2024	SELL	$12.33 - $18.83 $126,752 - $193,572	-10,280 Reduced 27.52%	27,070 $484,000
Q3 2023 Nov 13, 2023	BUY	$14.82 - $17.52 $553,527 - $654,372	37,350 New	37,350 $566,000
Q1 2023 May 12, 2023	SELL	$11.74 - $14.12 $487,656 - $586,516	-41,538 Reduced 74.59%	14,150 $185,000
Q4 2022 Feb 13, 2023	BUY	$10.01 - $13.9 $418,117 - $580,603	41,770 Added 300.11%	55,688 $675,000
Q3 2022 Nov 15, 2022	BUY	$13.31 - $23.25 $47,370 - $82,746	3,559 Added 34.36%	13,918 $193,000
Q2 2022 Aug 15, 2022	BUY	$15.73 - $22.91 $162,947 - $237,324	10,359 New	10,359 $196,000

173

35.8M

33K

900

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.27B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.